CLVS   $0.078  -5.00% Market Closed

Clovis Oncology Inc
Total Cash 94.58M
totalCashPerShare 0.655
EBITDA -208.50M
Total Debt 668.38M
quickRatio 0.971
currentRatio 1.173
Total Revenue 140.27M
debtToEquity
Revenue/Share 1.055
ROA -0.28021
ROE
grossProfits 115.30M
freeCashflow -116.45M
operatingCashflow -181.03M
earningsGrowth
revenueGrowth -0.127
grossMargins 0.76592004
ebitdaMargins -1.4863601
operatingMargins -1.54228
profitMargins -1.87703
enterpriseValue 724.06M
forwardPE -0.08371134
floatShares 142.41M
sharesOutstanding 129.98M
sharesShort 31.49M
sharesShortPriorMonth 33.16M
dateShortInterest
sharesPercentSharesOut 0.22%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.31%
Short Ratio help_outline 14.11%
shortPercentOfFloat 0.22%
impliedSharesOutstanding
bookValue -1.531
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -263.30M
trailingEps -4.38%
forwardEps -1.68%
enterpriseToEbitda -3.47
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.41 3Q 2022
institutionsCount 155
lastUpdated Feb. 19, 2023, 1:29 p.m.